Approval · Notice of Compliance 570 · 2002
COPAXONE: Notice of Compliance 570
Issued March 20, 2002
A Notice of Compliance is Health Canada’s approval of a drug submission: a new drug, a new use or form, or a change to an approved one. The product itself is in the Drug Product Database, with its current status.
- Notice number
- 570
- Date
- March 20, 2002
- Company
- Teva Pharmaceuticals Usa
- Product type
- Prescription Pharmaceutical
- Submission
- Supplement to a New Drug Submission (SNDS), supplement
- Submission class
- Other
- Reason
- New dosage format: pre-filled syringe
- Therapeutic class
- Immunomodulator
Products in this notice
| Brand | DIN | Status today |
|---|---|---|
| COPAXONE | 02245619 | Marketed |
Medicinal ingredients
- GLATIRAMER ACETATE 20 MG per ML